Fig. 1. Flow chart of research samples
Ann Clin Microbiol 2023;26:103-115. Clinical usefulness of procalcitonin/albumin and blood urea nitrogen/albumin ratios for the early detection of bacteremia Download image
Fig. 3. Residual biofilm percentage after treatment of study detergents. The percentage OD620 after treatment divided by baseline OD620 before detergent treatment was expressed in gray scale with shaded box for the corresponding range. The shade and biofilm removal of each well were inversely correlated. The study detergents included two enzymatic cleaners EmpowerTM (Metrex, Orange, CA), CidezymeTM (Johnson and Johnson Medical Inc, Arlington, TX), one non-enzymatic cleaner Matrix mintTM (Whiteley Medical, Sydney, Australia). A chlorine bleach YuhanroxTM Regular (Yuhanclorox, Seoul, Korea) was also tested as a control. Abbreviations: DW, distilled water; RT, room temperature.
Ann Clin Microbiol 2023;26:117-124. Evaluation of the efficacy of three medical device detergents on bacteria and yeast derived biofilm: a comparative study Download image
Fig. 2. Biofilm formation of S. aureus RN9120 in response to alcohol and salt supplement. The standard errors of OD620 of triplicated experiments were expressed as error bars. * denoted statistically significance.
Ann Clin Microbiol 2023;26:117-124. Evaluation of the efficacy of three medical device detergents on bacteria and yeast derived biofilm: a comparative study Download image
Fig. 1. Quantification of biofilm formation of each strains among gram-negative rods (A) and gram-positive cocci and yeasts (B) using measuring optical density of crystal violet stained biomass at 620 nm. The standard errors are expressed as error bars. The strains marked with asterisks are submitted to the evaluation of biofilm removal. Type strain names were shaded and the strains derived from clinical isolates were given names starting with AMC.
Ann Clin Microbiol 2023;26:117-124. Evaluation of the efficacy of three medical device detergents on bacteria and yeast derived biofilm: a comparative study Download image
Fig. 3. The time to positivity (TTP) of aerobic and anaerobic bottles among six most frequent organisms. Each of the white and black arrow heads denoted T50 of aerobic bottles and anaerobic bottles, respectively. The TTP for P. aeruginosa displayed only for aerobic bottles. CNS, coagulase-negative staphylococci; T50, median time-to-positivity.
Ann Clin Microbiol 2023;26:125-137. Performance evaluation of 4-day versus 5-day blood cultures using the BD BACTEC FX system Download image
Fig. 2. Number of isolates by time to positivity in aerobic and anaerobic bottles. The white, black, and gray arrow head denoted T50 of aerobic bottles, anaerobic bottles, both bottles, respectively. T50, median time-to-positivity.
Ann Clin Microbiol 2023;26:125-137. Performance evaluation of 4-day versus 5-day blood cultures using the BD BACTEC FX system Download image
Fig. 1. Cumulative percentages of positive blood cultures according to time-to-positivity.
Ann Clin Microbiol 2023;26:125-137. Performance evaluation of 4-day versus 5-day blood cultures using the BD BACTEC FX system Download image
Fig. 1. Overall view of the isolation room within the intensive care unit (A) and the sink (B) (arrow points to the location of the sink)
Ann Clin Microbiol 2023;26:159-163. Environmental culture for carbapenemase-producing Enterobacterales Download image
Fig. 1. Morphological and molecular findings of Taenia saginata found in this case. (A) After praziquantel (10 mg/kg) treatment, long parasite segments approximately 84 cm in length were expelled. (B) The 1750-bp cox1 sequence was yielded from our specimen and the neighbor-joining tree showed that our specimen (indicated by arrow head) was in the same phylogenetic group as T. saginata, but not in the same group as T. asiatica, T. multiceps, or T. solium.
Ann Clin Microbiol 2023;26:165-169. Taenia saginata infection incidentally detected during workup for lymphoma from an 8-year-old boy in Korea: a case report Download image
Fig. 2. Timeline depicting the discovery of factors crucial for GBS vaccine development. CPS, capsular polysaccharide; GBS, Group B Streptococcus; CDC, Centers for Disease Control and Prevention; ACOG, the American College of Obstetricians and Gynecologists; AAP, the American Academy of Pediatrics; WHO, World Health Organization.
Ann Clin Microbiol 2023;26:41-50. Group B Streptococcus vaccines: progress and potential Download image